Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

BACKGROUND: Basal-like breast cancer has been extensively characterized on the basis of gene expression profiles, but it is becoming increasingly common for these tumors to be defined on the basis of immunohistochemical (IHC) staining patterns, particularly in retrospective studies where material fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tischkowitz, Marc, Brunet, Jean-Sébastien, Bégin, Louis R, Huntsman, David G, Cheang, Maggie CU, Akslen, Lars A, Nielsen, Torsten O, Foulkes, William D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948892/
https://www.ncbi.nlm.nih.gov/pubmed/17650314
http://dx.doi.org/10.1186/1471-2407-7-134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948892/
https://www.ncbi.nlm.nih.gov/pubmed/17650314
http://dx.doi.org/10.1186/1471-2407-7-134

Ejemplares similares